Visit JCR Japan
Visit JCR Japan
Home
Who we are
Innovation
Pipeline
Patients & families
Our commitment
Partnerships
Investors & media
Our products
Contact us
Chris Miller
Notice of orphan drug designation for JR-446 for mucopolysaccharidosis type IIIB by European Commission (EC)
by Chris Miller
Privacy Preference Center
Privacy Preferences